Pakistan faces significant challenges in cervical cancer prevention, including the absence of a national cancer registry, limited screening services, and lack of HPV vaccine availability in the public sector. Current data are hospital-based, underestimating true incidence, with cervical cancer ranking as the third leading cause of female cancer deaths. Screening remains opportunistic and largely confined to private facilities, while HPV testing and liquid-based cytology are scarce. Efforts are underway to establish a national registry, introduce HPV vaccination through Gavi support, and expand visual inspection with acetic acid (VIA) screening. Barriers include social stigma, financial constraints, and limited access to specialized care, particularly in rural areas. Proposed solutions emphasize advocacy, integration of vaccination into the EPI schedule, self-sampling approaches, training of gynecologists, and hybrid awareness campaigns to accelerate progress toward WHO’s 2030 elimination targets.